Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
496600
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Monthly exercise status of stock acquisition rights with an exercise price adjustment clause
発行・処分する株式数
New shares 496,600 new shares issued during the month / Treasury shares 0 shares (no treasury shares transferred)
発行済株式総数
1.65% (496,600 shares issued during the month across all series / 30,262,600 listed shares as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
The exercise prices during the month were ¥232.1, ¥241.3, ¥241.8, ¥248.4, ¥249.8, ¥262.1, ¥268.9, ¥289.7, ¥305.2, ¥277.8 and ¥272.6. Details of the adjustment provisions and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 74,600 rights; exercised during the month: 4,966 rights; unexercised at month-end: 69,634 rights
Procedures under the Corporate Code of Conduct
The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments.
Most recent equity financing
30 March 2026: Issuance of the Seventh Series of Stock Acquisition Rights (with Provisions for Adjustment of the Exercise Price). Total issued: 74,600 rights (7,460,000 shares)
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly exercise status of stock acquisition rights with an exercise price adjustment clause |
| Number of shares to be issued or disposed of | New shares 496,600 new shares issued during the month / Treasury shares 0 shares (no treasury shares transferred) |
| Dilution Rate | 1.65% (496,600 shares issued during the month across all series / 30,262,600 listed shares as of the payment date for the issuance) |
| Total number of issued shares | 30,262,600 shares as of the end of the month preceding the reporting month → Not disclosed |
| Exercise price | The exercise prices during the month were ¥232.1, ¥241.3, ¥241.8, ¥248.4, ¥249.8, ¥262.1, ¥268.9, ¥289.7, ¥305.2, ¥277.8 and ¥272.6. Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 74,600 rights; exercised during the month: 4,966 rights; unexercised at month-end: 69,634 rights |
| Procedures under the Corporate Code of Conduct | The disclosure describes compliance with exercise restrictions pursuant to Article 434 of the Tokyo Stock Exchange Rules on Listing of Securities and the Japan Securities Dealers Association Rules Concerning the Handling of Third-Party Allotments. |
| Most recent equity financing | 30 March 2026: Issuance of the Seventh Series of Stock Acquisition Rights (with Provisions for Adjustment of the Exercise Price). Total issued: 74,600 rights (7,460,000 shares) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the Seventh Series of Stock Acquisition Rights in April 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.